11
Supporting people with active and advanced disease •Need better data collection •Discussion at MDT – new diagnosis support •Identify best practice •Early palliative care support improves quality and quantity of life

Supporting people with active and advanced disease

Embed Size (px)

DESCRIPTION

Supporting people with active and advanced disease. Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative care support improves quality and quantity of life. What is the economic evidence behind survivorship?. - PowerPoint PPT Presentation

Citation preview

Page 1: Supporting people with active and advanced disease

Supporting people with active and advanced disease

• Need better data collection

• Discussion at MDT – new diagnosis support

• Identify best practice

• Early palliative care support improves quality and quantity of life

Page 2: Supporting people with active and advanced disease

What is the economic evidence behind survivorship?

‘Routes from Diagnosis’ is a way of linking and analysing routinely collected data

Maps the cancer journey from diagnosis through to death

Describing health outcomes i.e. survival times, incidence, prevalence of cancer and non related cancer morbidities.

Tells us how patients interact with the system e.g. interaction with health care services, when, how long and cost

Page 3: Supporting people with active and advanced disease

All patients reach one of these outcome groups – taking different routes from diagnosis

Diagnosis

0-12 months

1-7 years, cancer

complications

7+ years, no complications

This is a survivorship outcome framework

1-7 years, other morbidities

1-7 years, no complications

7+ years, morbidities

25.3%

29.7%

5.9%

20.4%

6.3%

12.4%

SIMPLIFIED

EXAMPLE

Everyone diagnosed with prostate cancer in England in 2004

Page 4: Supporting people with active and advanced disease

What does RfD tell us?

We know more about clinical

outcomes – beyond just

survival We know more about how they interact with the system

Page 5: Supporting people with active and advanced disease

Insight – Health economics

Page 6: Supporting people with active and advanced disease

Different ‘Routes

from Diagnosis’

3 final CR survivorship pathways for testing

Interventions tailored for each ‘Route from

Diagnosis’

Designing effective Service Solutions

Page 7: Supporting people with active and advanced disease

Exciting new research• Macmillan working with NCIN and Imperial College London to produce evidence on main drivers of cancer costs.

• Cost data will allow comparison of alternative pathways of care.

• Investigate variation in costs in England across lung, breast, prostate and bowel cancer:

• Economic burden of cancer

• Differences in the cancer care pathways and their effects on patient survival and costs

• Cost of emergency admissions of patients with cancer

Page 8: Supporting people with active and advanced disease

Supporting people with active and advanced disease

• Need better data collection

• Discussion at MDT – new diagnosis support

• Identify best practice

• Early palliative care support improves quality and quantity of life

Page 9: Supporting people with active and advanced disease

Key survivorship messages

• A shift in professional culture is essential to enable supported self management.

• New models of cancer aftercare gives opportunities to improve quality and reduce cost.

• Many people can self manage their health with support, with rapid access to professionals when needed.

• There is significant unmet need arising from consequences of treatment, which can be successfully addressed through prevention and treatment.

• Good survivorship care requires timely communication across boundaries.

Page 10: Supporting people with active and advanced disease

Aligning with the NHS Mandate in England

Page 11: Supporting people with active and advanced disease

Taking Action - a ‘how to guide’